These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 10685837)

  • 1. Androgen levels of patients with ankylosing spondylitis.
    James WH
    J Rheumatol; 2000 Feb; 27(2):556-7. PubMed ID: 10685837
    [No Abstract]   [Full Text] [Related]  

  • 2. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis.
    Toussirot E; Streit G; Nguyen NU; Dumoulin G; Le Huédé G; Saas P; Wendling D
    Metabolism; 2007 Oct; 56(10):1383-9. PubMed ID: 17884449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis.
    Imrich R; Rovensky J; Zlnay M; Radikova Z; Macho L; Vigas M; Koska J
    Ann Rheum Dis; 2004 Jun; 63(6):671-4. PubMed ID: 15140773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population.
    Niederer R; Danesh-Meyer H
    N Z Med J; 2006 Mar; 119(1230):U1886. PubMed ID: 16532040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacós et al.
    Golmia RP; Sousa BD; Scheinberg MA
    Arthritis Rheum; 2002 Dec; 46(12):3390-1; author reply 3392. PubMed ID: 12483748
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative statistical study of the results of laboratory investigations in patients with ankylosing spondylitis and in normal patients].
    SUCHY K; TRUHLAR P; MALY V
    Acta Chir Orthop Traumatol Cech; 1957 Jan; 24(1):27-37. PubMed ID: 13410421
    [No Abstract]   [Full Text] [Related]  

  • 7. Ankylosing spondylitis in Northern Jordan.
    Al-Amayreh IA; Zaidat BO
    Saudi Med J; 2000 Oct; 21(10):950-2. PubMed ID: 11369960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is disease severity in ankylosing spondylitis genetically determined?
    Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA
    Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antitrypsin phenotypes in patients with ankylosing spondylitis.
    Sierakowski S; Chwiećko J; Kita K
    Rocz Akad Med Bialymst; 2001; 46():54-9. PubMed ID: 11780580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab.
    Braun J; van der Heijde D; Doyle MK; Han C; Deodhar A; Inman R; de Vlam K; Burmester GR; Van den Bosch F; Xu S; Visvanathan S; Rahman MU
    Arthritis Rheum; 2009 Aug; 61(8):1032-6. PubMed ID: 19644896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis.
    Yang C; Gu J; Rihl M; Baeten D; Huang F; Zhao M; Zhang H; Maksymowych WP; De Keyser F; Veys EM; Yu DT
    Arthritis Rheum; 2004 Oct; 51(5):691-9. PubMed ID: 15478146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of blood picture tests in patients with ankylosing spondylitis].
    MAKAROV MP
    Khirurgiia (Mosk); 1960 Nov; 36():128-31. PubMed ID: 13765593
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of etanercept for treating ankylosing spondylitis].
    Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
    Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D;
    Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis.
    Chen CH; Liao HT; Chen HA; Liang TH; Wang CT; Chou CT
    J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis.
    Lange U; Teichmann J; Stracke H
    Eur J Med Res; 2000 Dec; 5(12):507-11. PubMed ID: 11147993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH; Lee HJ; Sung IH; Kim TH
    J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and treatment of ankylosing spondylitis: current status and future directions.
    Zochling J
    Curr Opin Rheumatol; 2008 Jul; 20(4):398-403. PubMed ID: 18525351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and clinical markers of disease activity in ankylosing spondylitis.
    Muñoz-Villanueva MC; Muñoz-Gomariz E; Escudero-Contreras A; Pèrez-Guijo V; Collantes-Estévez E
    J Rheumatol; 2003 Dec; 30(12):2729-32. PubMed ID: 14719229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.